The recent high-pressure tactics to introduce genetically engineered food crops in India are another rude reminder that Western agribusiness companies have a deeprooted strategy to obtain a stranglehold on India’s food and agriculture system. In a review of recent trends titled ‘Food Without Choice’ (The Tribune, November 1) Prof Pushpa M. Bhargava (who was nominated by the Supreme Court in the Genetic Engineering Approval Committee to protect safety concerns), an internationally...

Stocks exceed the buffer norm despite dip in production ‘FCI machinery should be geared up’ The Union government on Wednesday ruled out the likelihood of rice imports on its account, as stocks were more than the buffer norm despite an expected dip in production due to drought in the kharif season. Speaking to journalists on the sidelines of the annual general meeting of the Indian Council of Agriculture Research, Union Agriculture and Food...

Minutes before curtains were drawn on state legislature's winter session, Chief Minister Ashok Chavan announced a Rs 10,000 crore package for Vidarbha. "This a time-bound programme for all-round development of the region and will be implemented in three years," said Chavan assuring the house that he would personally monitor it in co-ordination with the chief secretary. A quick analysis of the package, however, showed it was a re-jig of ongoing...

Interview with Joan Mencher, an anthropologist who has worked in India for long on issues such as agriculture, ecology and caste.   JOAN P. MENCHER is a Professor emerita of Anthropology from the City University of New York’s Graduate Centre and Lehman College of the City University of New York. She is the chair of an embryonic not-for-profit organisation, The Second Chance Foundation, which works to support rural grass-roots organisations...

Brazil and India are now among the top five government supporters of Research into third-world diseases, according to a study issued last week, which found that middle-income nations are taking on more of the burden of ills afflicting their poorest citizens. The study, by the George Institute for International Health, based in Australia, found that nearly $3 billion was spent last year on new drugs or products for such diseases. Brazil...